Source comparison
CJC-1295 no DAC & Ipamorelin Dosage Protocol Guide: Clinical Parameter Comparison
Standard Dose Range 100–200 mcg per injection 200–300 mcg per injection Both compounds administered simultaneously in separate syringes Injection Frequency 1–3 times daily Matched timing. Morning + pre-sleep minimum Half-Life ~30 minutes ~2 hours Ipamorelin's
This comparison does not assign a generated winner or score.
- Standard Dose Range
- 100–200 mcg per injection
- 200–300 mcg per injection
- Both compounds administered simultaneously in separate syringes
- Injection Frequency
- 1–3 times daily
- Matched timing. Morning + pre-sleep minimum
- Half-Life
- ~30 minutes
- ~2 hours
- Ipamorelin's longer half-life extends the GH release window initiated by CJC-1295
- Optimal Timing
- 30+ minutes pre-meal or 90+ minutes post-meal
- Same fasting requirement
- Align with circadian GH peaks: upon waking, post-exercise, pre-sleep
- Reconstitution Stability
- 28 days refrigerated (2–8°C) in bacteriostatic water
- Both vials require identical cold-chain storage
- Professional Assessment
- Short half-life preserves pulsatile GH pattern critical for metabolic signaling
- Selective ghrelin receptor agonist with minimal cortisol or prolactin elevation
- Synergistic mechanism: CJC amplifies Ipamorelin's pulse by blocking somatostatin suppression